ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000785.1|O-antigen_1 # 152 # 1000 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.706	BGC0000785.1|O-antigen_1 	152	1000	-	Loose	600	27.335	APH(9)-Ia	24.53	3002662	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(9)	ATGACAAATTTCTCCAGCAGCCCGCCGATCGCTTTCGGCGACCTCCAGGGCTGCCACGCCGCCTATCGGCAGCTCTTCGACACGCTCGCGCCGGCGGCCGACACCCCGCTCTGGTTCGCGGGCGACCTCGTCAACCGCGGCCCGGCCTCGCTCGCGACGCTGCGCGAGATCGCCGCGCTCGGCGAGCGCGCGATCGCGGTGCTCGGCAATCATGATCTGCACCTGCTCGCGGTCGCGGCCGGGATCCGCACGCTGAAGCCGGGCGACTCGATCGGCGAGATTCTATACGCGCCCGACGCCGACGATCTGATCGAATGGGTGCGCCACCGGCCGTTCGCGCACTTCGAGCGCGGCATGCTGATGGTGCACGCGGGCCTGCTGCCGCAATGGGACGCGGCGCTCGCGCTCGAACTCGCCGACGAACTTCAGCGCGCGTTGCGCGCGTCGAACTGGCGCGACACGCTGCGCAGCCTGTACGGCAACGACCCCAATTGTTGGAGCCCGGATCTGAAGCACGCGGACCGGCTGCGAGTCGCATTCAACGCGTTCACGCGCATTCGCTTCTGCACGCCGGAAGGCGCGATGGAGTTTCGGGCGAACGGCGGCCCGGCGGCCGCGCCCGCCGGCTACCTGCCCTGGTTCGACGCGCCCGGACGGAAAACCGCCGACGTGACGGTCGTGTTCGGCCACTGGGCCGCGTTGGGGCTGATGCTGCGCGAGAATCTGGTCGCGCTGGATTCGGGATGCGTGTGGGGCAACCGCCTGTCCGCCGTGCGGCTCGCCGACGATCCGGCCGCGCGCGTGGTCACGCAGGTCGCATGCGAGCGCTGCGGCGCACCGGACGAATAG	MTNFSSSPPIAFGDLQGCHAAYRQLFDTLAPAADTPLWFAGDLVNRGPASLATLREIAALGERAIAVLGNHDLHLLAVAAGIRTLKPGDSIGEILYAPDADDLIEWVRHRPFAHFERGMLMVHAGLLPQWDAALALELADELQRALRASNWRDTLRSLYGNDPNCWSPDLKHADRLRVAFNAFTRIRFCTPEGAMEFRANGGPAAAPAGYLPWFDAPGRKTADVTVVFGHWAALGLMLRENLVALDSGCVWGNRLSAVRLADDPAARVVTQVACERCGAPDE	MLKQPIQAQQLIELLKVHYGIDIHTAQFIQGGADTNAFAYQADSESKSYFIKLKYGYHDEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNGFTQNLTGKQWKQLGKVLRQIHETSVPISIQQQLRKEIYSPKWREIVRSFYNQIEFDNSDDKLTAAFKSFFNQNSAAIHRLVDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPKERDLMFIGGGVGNVWNKPHEIQYFYEGYGEINVDKTILSYYRHERIVEDIAVYGQDLLSRNQNNQSRLESFKYFKEMFDPNNVVEIAFATEQ	85.20	gnl|BL_ORD_ID|227|hsp_num:0	252			387	531	spectinomycin
BGC0000785.1|O-antigen_2 # 1378 # 2439 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.650	BGC0000785.1|O-antigen_2 	1378	2439	+	Loose	400	28.1054	JOHN-1	27.91	3000840	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	JOHN beta-lactamase	ATGATCTTGGTAACGGGCGGCGCCGGTTTCATCGGCGCCAACTTCGTGCTTGACTGGCTGGCTCAATCCGACGAGGCGGTGCTGAACGTCGATAAGCTGACGTACGCGGGCAACCTCGGCACGTTGAAGTCGTTGCAGGGGAATCCGAAGCATGTATTCGCCCGCGTCGACATCTGCGATCGCGCCGCAATCGACGCGCTGCTGGCGCAGCACAAGCCGCGCGCGATCGTGCACTTCGCGGCCGAGAGCCACGTCGACCGTTCGATTCACGGTCCGGCCGATTTCGTGCAGACGAACGTCGTCGGCACCTTCACGCTGCTCGAAGCCGCGCGCCAATACTGGAGCGCGCTCGGCACCGACGCGAAGGCGGCGTTCCGCTTCCTGCACGTATCGACGGACGAAGTGTTCGGCTCGCTGTCGCCGGCCGATCCGCAGTTCTCCGAAACCACGCCGTACGCGCCGAACAGCCCGTACTCGGCGACGAAGGCGGGCTCCGACCACCTCGTACGCGCGTATCACCACACGTACGGGTTGCCGGTGCTCACGACGAACTGCTCGAACAACTACGGCCCGTATCAGTTCCCCGAGAAGCTGATTCCGCTGATGATCGCGAACGCGCTCGGCGGCAAGCCGCTGCCCGTCTACGGCGACGGCCAGAACGTGCGGGACTGGCTGTACGTCGGCGATCACTGCAGCGCGATTCGCGAGGTGCTCGCGCGCGGCGTGCCGGGCGAGACGTACAACGTCGGCGGCTGGAACGAAAAGAAGAATCTCGATGTCGTGCACACGCTGTGCGATCTGCTCGACGAGGCCCGGCCGAAGGCGGGCGGCTCGTACCGCGATCAGATCACGTACGTGACCGATCGCCCCGGCCACGATCGCCGCTATGCGATCGATGCGCGCAAGCTCGAGCGCGAGCTCGGCTGGAAGCCGGCCGAGACGTTCGAGACCGGACTTGCGAAGACCGTGCGCTGGTATCTCGACCATCAGGAGTGGGTCGACGAAGTGGTGTCGGGCGATTACCGCAAGTGGGTCGAAACGAACTACGCGCAACGCGCGTAA	MILVTGGAGFIGANFVLDWLAQSDEAVLNVDKLTYAGNLGTLKSLQGNPKHVFARVDICDRAAIDALLAQHKPRAIVHFAAESHVDRSIHGPADFVQTNVVGTFTLLEAARQYWSALGTDAKAAFRFLHVSTDEVFGSLSPADPQFSETTPYAPNSPYSATKAGSDHLVRAYHHTYGLPVLTTNCSNNYGPYQFPEKLIPLMIANALGGKPLPVYGDGQNVRDWLYVGDHCSAIREVLARGVPGETYNVGGWNEKKNLDVVHTLCDLLDEARPKAGGSYRDQITYVTDRPGHDRRYAIDARKLERELGWKPAETFETGLAKTVRWYLDHQEWVDEVVSGDYRKWVETNYAQRA	MRKLASIILFLAAVSNSLGQSKNSPLQISHLTGDFYVYRTFNDYKGTKISANAMYVVTDKGVVLFDAPWDKTQFQPLLDSIKAKHNKEVVMLFGTHSHEDRAGGFDFYKKKGIKTYSIKLTDDILKKNKEPRAEFIISNDTTFTVGNHTFEVYYPGKGHAPDNIVAWFKKEKILYGGCFVKSAEALDLGYLGDADVKEWQKSIKKVQAKFKKPDYIISGHDDWTSKESLNHTLKLVDEYLAQKSAGKK	142.34	gnl|BL_ORD_ID|297|hsp_num:0	222			231	354	
BGC0000785.1|O-antigen_3 # 2451 # 3344 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.631	BGC0000785.1|O-antigen_3 	2451	3344	+	Loose	200	29.261	FosX	31.48	3000198	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGGCGCGCAAGGGCATTATTCTGGCCGGCGGTTCCGGCACGCGGCTGTATCCGATCACGCATGCGGTGTCGAAGCAGCTGTTGCCGGTCTACGACAAGCCGATGATCTATTACCCGCTGTCGACGCTGATGGTGGCGGACATTCGCGATGTGCTGATCATCTCGACGCTGCAGGACACGCCGCGCTTCGAGGCGATGCTGGGTGACGGCAGCCAGTGGGGGATGAACATCCGCTACGCGGTGCAGCCGTCGCCGGACGGGCTCGCGCAGGCGTTCGTGATCGGCCGGGAATTCGTCGGCCGCGATCCGTCGACGCTTATTCTCGGCGACAACATCTTCTATGGCCACGATCTCGCGAAGCAACTCGATCGGGCATCGGCGCGGCAGGCGGGTGCGACGGTGTTCGCATACCACGTGCACGATCCGGAGCGCTACGGCGTCGTCGAGTTCGACGGCGAATTCCGCGCGCTGTCGATCGAGGAGAAGCCCGCGAAGCCGCGCTCGAACTACGCGGTGACGGGGCTGTACTTCTACGACAACCAGGTGTGCGACATCGCGGCGGACATCAAGCCGTCCGCGCGCGGCGAGCTGGAGATCACGGACGTGAATTCCCGCTATCTCGCCGCGGGTTTGCTCGACGTCGAGATCATGGGCCGCGGCTACGCGTGGCTCGATACCGGCACGCACGATTCGCTGATCGAGGCGGCGACGTTCATCGCGACGCTGCAAAAGCGCCAGGGGCTCGTCGTCGCGTGTCCGGAGGAGATCGCGTATCGGCGGCAGTGGATCGACGCGGAACAACTGCTCAAGCTCGCACAGCCTTTGTCGAAAAATGGCTATGGCCAGTACCTGAAAAACATTCTTACGGATCAAGTCGCATGGCCATCCAAGTAA	MARKGIILAGGSGTRLYPITHAVSKQLLPVYDKPMIYYPLSTLMVADIRDVLIISTLQDTPRFEAMLGDGSQWGMNIRYAVQPSPDGLAQAFVIGREFVGRDPSTLILGDNIFYGHDLAKQLDRASARQAGATVFAYHVHDPERYGVVEFDGEFRALSIEEKPAKPRSNYAVTGLYFYDNQVCDIAADIKPSARGELEITDVNSRYLAAGLLDVEIMGRGYAWLDTGTHDSLIEAATFIATLQKRQGLVVACPEEIAYRRQWIDAEQLLKLAQPLSKNGYGQYLKNILTDQVAWPSK	MISGLSHITLIVKDLNKTTAFLQNIFNAEEIYSSGDKTFSLSKEKFFLIAGLWICIMEGDSLQERTYNHIAFQIQSEEVDEYTERIKALGVEMKPERPRVQGEGRSIYFYDFDNHLFELHAGTLEERLKRYHE	223.31	gnl|BL_ORD_ID|111|hsp_num:0	129			210	363	fosfomycin
BGC0000785.1|O-antigen_4 # 3329 # 3880 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.558	BGC0000785.1|O-antigen_4 	3329	3880	+	Loose	700	27.335	ACT-36	31.11	3003171	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGGCCATCCAAGTAACTGCTACCGCTTTGCCGGAAGTCAAGATTATCGAACCGAAGGTATTCGGCGATGCTCGCGGATTCTTCTTCGAGAGCTTCAATGCTCGAGAATTTACAGAACTCGTTGAGCCGGGCATCGAATTCGTTCAGGACAATCACTCCCGATCCGCCCGTGGCGTGCTTCGCGGCCTGCACTATCAAATTCAGCACGCGCAAGGGAAACTCGTGCGTGTAGTCGACGGCGAAGTGTTCGACGTCGCGGTCGATGTCCGGAGGAGTTCGCCCAATTTCGGTAAGTGGGTTGGCGTACGGCTGTCTGCGGAGAACAAGCGGCAGCTTTGGGTGCCGGCGGGCTTCGCGCATGGCTTCGTTGTACTGAGCGAATCAGCGGATTTTCTGTACAAGACGACCGACTATTGGTATCCGGAGTTTGAGCGGAGCATCCTTTGGAGCGACAAGCAAATCGGTATCGAATGGCCGATTGATCGGGAGCCGCTTGTTGCTGCAAAGGATGCCGCGGGCAAGGCGATTAGCGAAGCCGAGGTCTATGCATGA	MAIQVTATALPEVKIIEPKVFGDARGFFFESFNAREFTELVEPGIEFVQDNHSRSARGVLRGLHYQIQHAQGKLVRVVDGEVFDVAVDVRRSSPNFGKWVGVRLSAENKRQLWVPAGFAHGFVVLSESADFLYKTTDYWYPEFERSILWSDKQIGIEWPIDREPLVAAKDAAGKAISEAEVYA	MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHYYTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGALTVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPENVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEANTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILDALQ	48.03	gnl|BL_ORD_ID|610|hsp_num:0	663			651	786	
BGC0000785.1|O-antigen_5 # 3877 # 4773 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.630	BGC0000785.1|O-antigen_5 	3877	4773	+	Loose	200	28.8758	vanH gene in vanD cluster	27.05	3002944	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGAAGATTTTGGTGACGGGGGCAAACGGCCAAGTGGGCTGGGAACTCGCTCGGAGTCTGGCGGTATTGGGGCAAGTTGTCCCGCTCACGCGTGAGCAGGCCGATCTCGGCCGCCCCGAAACGCTTGCTCGAATTGTTGAGGACGCGAAGCCGGATGTCGTCGTCAATGCTGCGGCATATACGGCGGTCGATGCTGCGGAAACCGATGGTGCTGCAGCGAATGTGATCAACGGTGAGGCGGTAGGTGTGCTGGCCGCCGCGACGAAGCGTGTCGGCGGCTTGTTCGTTCATTACTCGACGGACTACGTTTTTGACGGCACCAAGCCGTCGCCATACATCGAGACGGATCCGACGTGTCCCGTCAATGCCTACGGCGCCAGCAAGTTGCTGGGAGAGTTGGCGGTTGCGGAGACCGGCGGCGACTGGCTGACGTTTCGCACCACGTGGGTGTTCGCCGCACGCGGCAAGAACTTCCTGCGAACGATGCTTCGTCTTGCCAAGGAGCGCGAAGAGATGAAGATCGTGGCCGATCAGTTCGGCGCGCCGACCTGGGCGCGATCGATTGCTGACGGCACGGCCCACGCGCTCACGACCGCGATGCGTGAACGCGCGGCAGGCGCGTTCACGTCCGGCGTCTATCACATGACATCCGCGGGGCAGACTTCATGGCACGGTTTCGCGGACGCGATCATCGCATCCTGGCGAGCGGCTCCGGGGGCGGCACCGCTCGCCGTCAGCCGGATCGTGCCGATTCCGGCGAGCGCCTATCCCGTGCCGGCACAGCGCCCGGCAAACTCGGTACTGTCGAACAAGGCGCTGAAAGAGCGTTTCGGTATCGAACTGCCTGATTGGCGGTATGCACTACGGCTGTGCGTCAACGATCTGCTTTTCCAATGA	MKILVTGANGQVGWELARSLAVLGQVVPLTREQADLGRPETLARIVEDAKPDVVVNAAAYTAVDAAETDGAAANVINGEAVGVLAAATKRVGGLFVHYSTDYVFDGTKPSPYIETDPTCPVNAYGASKLLGELAVAETGGDWLTFRTTWVFAARGKNFLRTMLRLAKEREEMKIVADQFGAPTWARSIADGTAHALTTAMRERAAGAFTSGVYHMTSAGQTSWHGFADAIIASWRAAPGAAPLAVSRIVPIPASAYPVPAQRPANSVLSNKALKERFGIELPDWRYALRLCVNDLLFQ	MQEKIDITVFGCERDEAAVFRKLSSEYGVTVSLIEDVVSEHNAKLADGCQCVSVSHKAELSEQLLLALKHAGVKYISTRSIGFNHIDIQAAGQLGMAVGTVAYSPGSVADYTVMLMLMLLRGTKSVLRGTQKQNYCLNDCRGKELQDLTVGVLGTGRIGQAVMERLEGIGCKVLAYDRTHKAGANYVSFCELLKSSDIVTLHVPLAEDTRHMIGREQLEMMKREALLINTARGALVDTAALVAALKEQKIGGAALDVLEGEEGIFYHECTQKTIGHPYLSVLQKMPNVIVTPHTAYHTDRVLVDTVSNTIRNCLNFERSLGNV	92.26	gnl|BL_ORD_ID|1348|hsp_num:0	1333			546	858	vancomycin; teicoplanin
BGC0000785.1|O-antigen_6 # 4800 # 5633 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.558	BGC0000785.1|O-antigen_6 	4800	5633	+	Loose	500	37.7354	tetB(58)	19.31	3003981	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCGATAATTAGTGTTTTTACCTCTGCTCCGGGAGATCTCGTAAGCTCGGTCGCGCGGAACGCTTCGCTCATCTGGCAGATGACGAAGCGGGAAGTCGTCGGCCGCTATCGCGGGTCCGTACTCGGCTTGGCTTGGTCCTTCTTCAATCCGCTGCTGATGCTTGCGGTGTATTCGTTCGTCTTTTCCTTTGTCTTCAAGTCGAGATGGGGAGGGGGCGCGGAGGATCAGGGGCGTGCGCAATTTGCGATGATGCTGTTCGTCGGCATGACGATTCATGGATTGTTCGCCGAATGTGTCAATCGAGCGCCGAGTCTGATCCTGAACAATCCGAGCTATGTGAAGAAGATCGTGTTTCCGCTGGAAATACTGCCTATCGTCGCGCTTCTGTCCGCCTTCTTCCATACCCTCGTCAGTCTTGCGGTGCTGCTGCTGGGTTTCGCCCTGTTCAAGCATTTCGTTTTCGCAAGTGCGTTGTTTTTGCCGATTGTCCTGTTGCCACTGATGCTGATGTCGCTCGGCGTGGCTTGGTTTCTGGCCGCCACCGGCGTGTTCGTGAGGGATGTCGGGCAGATTACGGGCTTGTTCACGATGGTGCTGATGTTCCTGTCACCGGTGTTTTATCCGGCATCCGCGTTGCCGGAAAAGTATCGTTTCTGGCTGGAGCTCAATCCGCTGACGCTATTCATCGAGCAGTCACGCGGGATACTTCTCGAAGGCAGAGTGCCGGATTTCCATCCGCTCGGCCTCGCGTTTTTGGGGGGCGTGGCCGTTGCGTGCGCGGGCTTCAAGTATTTTCAGTTAATGCGCAAGGGGTTTGCCGATGTCCTCTGA	MSIISVFTSAPGDLVSSVARNASLIWQMTKREVVGRYRGSVLGLAWSFFNPLLMLAVYSFVFSFVFKSRWGGGAEDQGRAQFAMMLFVGMTIHGLFAECVNRAPSLILNNPSYVKKIVFPLEILPIVALLSAFFHTLVSLAVLLLGFALFKHFVFASALFLPIVLLPLMLMSLGVAWFLAATGVFVRDVGQITGLFTMVLMFLSPVFYPASALPEKYRFWLELNPLTLFIEQSRGILLEGRVPDFHPLGLAFLGGVAVACAGFKYFQLMRKGFADVL	MSSSMIQPGTERQLKNRTSLGQTVRNSLTMAYRGLLKLRRTPEQLFDVTFQPIIFTLMFTYIFGGAISGDVASYLPVIIPGILVQTVITTSVVTGVQLREDMDKGVFDRFKSLPIARIAPLAGALLADTIRYTIATVLTFTMGYIMGYRPEGGLGYVALAGLVVILCSWAISWIFAFCGVIARSASGVQGISMIVLFPLTFLSNAFVPVDTMPGWLQWFVNMNPISHLVTAVRDLTNAGTVGWDLTISLVGAAVIVAIFAPITVRAYMRRT	102.21	gnl|BL_ORD_ID|4708|hsp_num:0	2518			42	723	tetracycline
BGC0000785.1|O-antigen_7 # 5623 # 7032 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.591	BGC0000785.1|O-antigen_7 	5623	7032	+	Loose	600	79.337	oleC	28.79	3003748	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTCCTCTGAATTGCCGGCAATCAGCGTCCAAGACGTCAGCAAGCGCTTTCGCGTATTTGCCAAGCCGGCAGACCGTCTGAAGGCCGCAGTTCGGCATCGCATCGGCGGTCTCGCGAAGTTGGTGCCCGCTCGTTTGCTCGGAACGGAAGGTGCAAGCGAGTTTCATGCGCTGCAGCATGTGTCGTTTCACGTACAAAAGGGCGAGACGATCGGAATCATCGGCCGCAACGGCTCGGGAAAGTCGACGTTGTTGCAGATCATCTGCGGGACGCTCACGCCGTCGGGTGGCCGGGTTGCGATCAACGGGCGCGTCGCCGCGCTGCTCGAACTCGGAGCGGGCTTCAATCCGGAGTTCACTGGCCGCGAAAACGTATACATGAACGCGGCGTTGCTGGGCCTCTCGAAAGCCCAGATCGAGGAGCGGCTCGACGCCATCTTCGCTTTTGCCGATATTGGCGGCTTCGTGGATCAACCGGTGAAGACCTATTCGAGCGGCATGTACGTGCGGCTTGCTTTTGCCGTCATTGCGCACGTCGACGCCGACGTGCTCGTGATCGACGAAGCGTTGGCCGTCGGGGACGCATTCTTCACGCAAAAGTGCATGCGTTTTCTGCGCGCGTTCATGGAGCGGGGCACCGTTTTATTTGTCAGCCACGATACGAACGCGGTGGTCAATCTCTGTACCCGCGTCGTATGGCTTGACAAGGGGCGCGTTCGCGAAATCGGTCCGGCAAAGGACGTTTGCGACTCGTATCTTGAGGCTTTCTACGAGGAGCAGCATTGCGCATCGGGGCGAAGCGTTCGCGCGCTTGAGCGCAGCAGTGTCGTGCGCGCAATAGCCGAAGGCGATATGCGCGACCAGCGCGCATTGCTCATCAACGCGTCGAAGCTGCGCAACGACGTGGAGTTGTTCCAGTTCACTGCCGACGCGAAGAATTTCGGTCTTGGCGGCGCATCGATTGAGCATGTCGGCATCGAGGATGGCACGGGGGCGCCGCTGAATTGGGTAGTGGGAGGCGAGATCGTTTGCATCCGCATCGCCGTCAAAGCCCTGCAGAACCTGGAGCGTGCCATCGTCGGATTCATTGTCCGGGATCGGCTCGGGCAAAATCTGTTTGGCGACAACACGTATCTCACGACCCTCAACGAGCCGTTCGCTGTCGCGGCGGGCGAAAGTTTTTCGGTCCGATTCGGGTTCAGAATGCCGGTCTTGCCGGTAGGCGATTATTCGGTGACGGTTGCAGTCGCCGACGGTTCACAAAGCGACCACGTGATCCACCAATGGCTGCACGATGCGGTGTTGTTGAAGTCGCATTCGACGAGTGTCAGTACAGGATTAATAGGTATTCCAATGCATGAGATCGTGCTTGAGCGGGATACGCTGAACGAAGTTGGGGCGGCGCAATGA	MSSELPAISVQDVSKRFRVFAKPADRLKAAVRHRIGGLAKLVPARLLGTEGASEFHALQHVSFHVQKGETIGIIGRNGSGKSTLLQIICGTLTPSGGRVAINGRVAALLELGAGFNPEFTGRENVYMNAALLGLSKAQIEERLDAIFAFADIGGFVDQPVKTYSSGMYVRLAFAVIAHVDADVLVIDEALAVGDAFFTQKCMRFLRAFMERGTVLFVSHDTNAVVNLCTRVVWLDKGRVREIGPAKDVCDSYLEAFYEEQHCASGRSVRALERSSVVRAIAEGDMRDQRALLINASKLRNDVELFQFTADAKNFGLGGASIEHVGIEDGTGAPLNWVVGGEIVCIRIAVKALQNLERAIVGFIVRDRLGQNLFGDNTYLTTLNEPFAVAAGESFSVRFGFRMPVLPVGDYSVTVAVADGSQSDHVIHQWLHDAVLLKSHSTSVSTGLIGIPMHEIVLERDTLNEVGAAQ	MTVRGLVKHYGETKALDGVDLDVREGTVMGVLGPNGAGKTTLVRILSTLITPDSGQATVAGYDVVRQPRQLRRVIGLTGQYASVDEKLPGWENLYLIGRLLDLSRKEARARADELLERFSLTEAARRPAGTYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVKAMVGDGVTVLLTTQYMEEAEQLASELTVVDRGRVIAKGGIEELKARVGGRTLRVRPVDPLQLRPLAGMLDELGITGLASTTVDTETGALLVPILSDEQLTAVVGAVTARGITLSSITTELPSLDEVFLSLTGHRASAPQDAEPARQEVAV	144.31	gnl|BL_ORD_ID|2050|hsp_num:0	2264			33	627	oleandomycin
BGC0000785.1|O-antigen_8 # 7029 # 8267 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.563	BGC0000785.1|O-antigen_8 	7029	8267	+	Loose	200	29.6462	vanT gene in vanE cluster	30.38	3002971	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGAAATCTGAAATACCTGTCACAGTTCCGGATCGATTCGATGCCGCCGACGTGCTGGGGGCGCCACAGTCCGCCCGCGTCGCGGATCCGTCGACACTTGCGAATCCCGCCGACCGGCTTTCGACCCACGACAACGGCTTCGGGCTGCTTCGCCTGCTGTTCGCGACGATGGTGCTTTGGGACCATGCGTTTCCTCTTGGCGGCTTCGGTGCCGACCCGATGTGGCGCCTGACGCTCAATCAGGATTCGATGGGGGGAATCTGCGTCTCCGGCTTCTTCGCGATCAGTGGATTTCTCATTGCGAAGAGCGGCATGCGAGCGGATGCGTTGCAGTTTGCGTGGCGCCGATGCGTGCGGATCTTTCCGGCGTACTGGGCGGTGCTGATCGTCACCGCGCTCTGTGTCGGGCCGATCATTCACTACGTGCAGGCGGGAACGCTGCATGGATATTGGAATGCAGCGCTTGGCGGTCCGCTGGGCTATATCACGAACAACTGGCGGCTCACGATCGGACAATATGGAATCAACGATCTGCTGCGAGACACGACACCCTATGGGCATTCGATTTCGGAGAGCGTGTTCAACGGCTCGATTTGGACATTGATATACGAGGCGAAATGCTATGTGATGGTCGGTCTTTTTGCGATGTTCGGACTTCTTACGGCGCACCGCAGGGTGTTGCTTGCCGTGACGGTTGTCGCATGGTTCGTACTCGCGATCCAGACTATCAATCCGGCATTCTCCGCTCAACTCCTCCCGTGGGCGGGAGATCGCCATCTCGTTCAATACGGAACGATTTTCCTGATTGGATCGAGTGCCGCAGCGTATTCGAAGAGTCTGCCGATTTCAGACAAACTGGGAGCGTTTGCTGTCGTCGTTTATCTGATTTCGTTGTTTAAGGGTGGATATCTGCTGCTTGGCTATCCGGCGATGGTATACGCGATCCTCTGGCTTGCTTGCCGTCTACCGCGCTGGGCGCGCCGGATCGGTTCCAGGAACGACTACTCGTATGGAATCTACGTGTTCGGTTTCCTGGTTCAGCAGGTTTTGGCGTACGTGGGGGCATACAAGTACGGTTTTGTTTTTTATCTTGCCGCCTCGGTGTTCTTTACCTTCATCTGCGCATGGTTCAGTTGGCATCTGATCGAGAAACGCGCCCTGGCGCTGAAGGATTGGGGGCCCGGACAAGGATGGAAGTACTGTTTGGCTAGATTGACTATGAAGAAAGAGGGAGTGTGA	MKSEIPVTVPDRFDAADVLGAPQSARVADPSTLANPADRLSTHDNGFGLLRLLFATMVLWDHAFPLGGFGADPMWRLTLNQDSMGGICVSGFFAISGFLIAKSGMRADALQFAWRRCVRIFPAYWAVLIVTALCVGPIIHYVQAGTLHGYWNAALGGPLGYITNNWRLTIGQYGINDLLRDTTPYGHSISESVFNGSIWTLIYEAKCYVMVGLFAMFGLLTAHRRVLLAVTVVAWFVLAIQTINPAFSAQLLPWAGDRHLVQYGTIFLIGSSAAAYSKSLPISDKLGAFAVVVYLISLFKGGYLLLGYPAMVYAILWLACRLPRWARRIGSRNDYSYGIYVFGFLVQQVLAYVGAYKYGFVFYLAASVFFTFICAWFSWHLIEKRALALKDWGPGQGWKYCLARLTMKKEGV	MKHRANGIDLFRIFAATMVVAIHTFPFQSIAPFLDEVITLTVFRVAVPFFFMITGYFLLGRLSLNFSYNNNQRVKKYLYKIGMIYLYSILLYFPLSLLNGTISLKMNILLLLKVFIFDGTFYHLWYFPASIIGTILVTLLLRSIGFKLTVAFSTCLYLVGLGGDSWYGITNQVPLLNKLYTFIFSWSDYTRSGVFFTPVFLCLGIFAYRVSKKLTASKILNLLFYVFIIGMTFESIFLHRFTNVKHDSMYLLLPSCALILFLMLLNWQPKLKVKESADLTLLVYILHPLVIVIVHSISKYIPILKNSLLNFLLVVVCSFILAQLLLNLKRKLRVSKQKIPFERASKEISASAIHHNINEIRKIIPKNTNIMGVVKANAYGCGMVEVAYELEKIGISFFCVATIEEAIALRKSGNQGDILILGYTHPNRINDIKKYNLIQSIVSEEHGKVLNLKKIPIRCHLQVDTGMHRLGVTPNVTIIQQMYLFSNLKIEGIYSHLGSSDSLEQESIARTNTQIFLFNNILSDLEQMGISYGYTHIQSSYGILNYPELSFDFVRIGILCYGFLSDYNSPTKIPIDLQPIVKVKASLITERIVEAGEYVGYGLGAKVEKRTRIGVVSIGYADGIPRALSNAKLTLEFKGQSIKQIGNICMDMMLVDLSEVEDISLNDELIVLPNISKIADEEQTITNELLSRLGSRLGTELN	58.69	gnl|BL_ORD_ID|4680|hsp_num:0	1308			15	222	vancomycin
BGC0000785.1|O-antigen_9 # 8267 # 9358 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.606	BGC0000785.1|O-antigen_9 	8267	9358	+	Loose	1200	26.1794	arnA	50.0	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAGCGACGTGAATGCAAGCTTGGTTGACGGGAAAAAGATCCTCGTGACCGGTGGGGCTGGCTTTATCGGCTGCGCGATATCGGAGCGACTCGCAGCGCGTGCAAGCCGCTACGTCGTAATGGACAACTTGCATCCGCAGATCCATGCGAGCGCGGTTCGTCCTGGCGCGCTTCACGAGAAAGCGGAACTCGTCGTTGCCGACGTCACGGACGCCGGTGCATGGGATGCGCTGCTGAGCGATTTTCAACCGGAAATCATCATACATCTGGCCGCCGAAACGGGCACGGGCCAATCGCTGACGGAAGCGAGTCGGCATGCGCTCGTCAACGTCGTCGGCACCACGCGGCTGACGGACGCGCTCGTCAAGCACGGCATCGTGGTCGAGCACATTCTGCTGACGAGCAGCCGCGCGGTCTATGGCGAAGGGGCATGGCAGAAGGACGATGGCACGATCGTTTATCCCGGCCAACGCGGGCGCGCCCAGCTCGAGGCTGCGCAATGGGATTTCCCGGGGATGACGATGCTGCCTTCGCGTGCGGACCGTACCGAGCCGCGGCCGACGAGCGTCTATGGTGCAACGAAGCTCGCGCAGGAACACGTACTGCGTGCATGGTCGCTCGCAACGAAAACGCCGCTGTCGATTTTGCGTCTGCAGAACGTTTATGGCCCGGGTCAATCGTTGACTAACTCCTATACCGGCATCGTCGCGCTTTTCTCTCGGCTTGCTCGCGAAAAGAAGGTGATTCCGCTCTATGAAGACGGCAATGTGACGCGCGATTTTGTCAGTATCGACGATGTGGCGGACGCCATTGTCGCGACGTTGGTGCGCACGCCGGAAGCACTTTCCCTTTTCGATATCGGCTCCGGACAGGCGACGAGCATTCTCGATATGGCTCGAATCATCGCGGCGCATTACGGCGCTCCCGAGCCGCAGATCAACGGTGCATTCCGCGACGGAGATGTACGACACGCGGCGTGCGACTTGAGCGAATCGTTGGCGAACCTTGGATGGAAGCCGCAGTGGTCGCTCAAACGCGGGATCGGCGAATTGCAGACCTGGATCGCGCAAGAGCTTGATCGCAAGAACTAG	MSDVNASLVDGKKILVTGGAGFIGCAISERLAARASRYVVMDNLHPQIHASAVRPGALHEKAELVVADVTDAGAWDALLSDFQPEIIIHLAAETGTGQSLTEASRHALVNVVGTTRLTDALVKHGIVVEHILLTSSRAVYGEGAWQKDDGTIVYPGQRGRAQLEAAQWDFPGMTMLPSRADRTEPRPTSVYGATKLAQEHVLRAWSLATKTPLSILRLQNVYGPGQSLTNSYTGIVALFSRLAREKKVIPLYEDGNVTRDFVSIDDVADAIVATLVRTPEALSLFDIGSGQATSILDMARIIAAHYGAPEPQINGAFRDGDVRHAACDLSESLANLGWKPQWSLKRGIGELQTWIAQELDRKN	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	54.83	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1035	polymyxin B
BGC0000785.1|O-antigen_10 # 9379 # 10302 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.595	BGC0000785.1|O-antigen_10 	9379	10302	+	Loose	400	26.5646	ErmW	27.27	3001306	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGCCACTGCACGATACGACAATCACCGGTCCCGCGTCCTTGCGGATTCAGTCGGTCCTGTATAACAACAGTCAGCAGCACATCGATACGGCTCTCGAGAGCATCGGCCGTGCCGCCGATCTGGCGATTGCGTCCGATGCGTTGTCATCGGTGGAAATCGCGTTGGGGGATTGCTCGCCGGAGCCGGTCTTTACGTCCGAAGAGATCGAGACGCGCGCCGCCAAACTGCGTCCGCAAGGCGTGACGCGGATTCAGTATACGTTCTTCGACGCGAATCTCGGGTCAGCCGCCGGACAGAATCGCCTGCTTGCCGATTTGCAGACCGATCTCGTGTTGATTCTGAACCCGGACACGGTGGTGGCGCCCAATATCTTCGGCGAACTGGTGCGGCCGATGCGCAAGCCAGGGGTGGGCATCGTCGAGGCAAGGCAGGTACCTATCGAGCACCCGAAGGATTACGATCCAGTCACGGGCGAGACGAGTTGGGCGGCGACTGCGTGTGCCCTCGTCTCATCAGCGGTCGCAAAGGAAGTTGATGGCTTTGATTCGGAAGCATTCTTCCTGTACTGCGATGACGTGGACTTTTCGTGGCGAGTAAGGCTTGCCGGTTACAAGGTGGTGTTTCAGCCGTCGGCGGCGCTGTTTCACGACAAACGCCTTTCGACGGCGGGCAAATGGATTGTCGGTGGAGCCGAGGAGTACTACTCGGCAGAGGCCGCGCTCATTCTCGCGCACAAATACTCGAATAGCGCATTGGCCGATCGTATCGAGCGCCAGCTCCTCGCCCAAGGCAGCGAAGTCGAAAAAAAGGCCGCCAGGAAGTATCGGGATCTCAAGGACGCCGGGAAACTGCCCGCCCAGATCGATCCCGGGCATCGCGTGGCGCAATTCATCGATGGCTTCTACGCGAAACACCGCTTCTAA	MPLHDTTITGPASLRIQSVLYNNSQQHIDTALESIGRAADLAIASDALSSVEIALGDCSPEPVFTSEEIETRAAKLRPQGVTRIQYTFFDANLGSAAGQNRLLADLQTDLVLILNPDTVVAPNIFGELVRPMRKPGVGIVEARQVPIEHPKDYDPVTGETSWAATACALVSSAVAKEVDGFDSEAFFLYCDDVDFSWRVRLAGYKVVFQPSAALFHDKRLSTAGKWIVGGAEEYYSAEAALILAHKYSNSALADRIERQLLAQGSEVEKKAARKYRDLKDAGKLPAQIDPGHRVAQFIDGFYAKHRF	MSSIRRRHAAASLDTPAVGGRHELGQNFLVDRGVCTRIAEVVSSTTAHPVLELGAGDGAITRALVAANLPVTALELDPRRVRRLQRTFADGVTVVHGDMLRYDFGPYPHHVVSTVPFSITTPLLRRLIGQRFWHTAVLLVQWEVARKRAGVGGTTMLTAASWPWYEFTLVERVPKTSFDPVPSVDGGILVIERRSAPLLDDRCVGDYQNLVREVYTGPGRGLAAILRTRLPGREVDAWLRRERVDPAALPRDLKAGHWASLYRLYREVGTRPAPAGRSVRARPGSVGPDRSLPPRGLRSGPPRARRRGGGA	98.71	gnl|BL_ORD_ID|1572|hsp_num:0	1714			108	273	erythromycin; josamycin
BGC0000785.1|O-antigen_11 # 10306 # 12030 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.593	BGC0000785.1|O-antigen_11 	10306	12030	+	Loose	500	28.4906	rmtE2	25.49	3004679	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGAATTCTGCAACTTACCAGTTCCACTATCACGAGTATTCGGTGTACAGCAATGTCGTTGGGCTGATCACGGAGTTCGGCGCGCGCGATGGCGTGCATTTGGACATCGGCTGTGGATATGGCGCGATCGCGGAACCCGTTCGCGACCTCGGGCTCACGTACATCGGTTTCGATGCCGACGAGGATTCGCTGCGGGATTTGCGATCGCGAGGCTTCGAGGCGAAGCGAATCGACCTGCACCGTCTGGACGAGGTGTTCGCGGAGATTGCGGCCACGGTCAACGGTCGCAATGTGGCGTCGATTTCAATTATCGATACGCTGGAGCATATTACAAATGGGCCGGCGTTGCTCGACCGTCTGCGCGAGTTCGCCGAGCAGCGTTCGATTCTGCTCGTGGTCAGCGTGCCGAACGGCGGGCATCGCGATCTCGGTGCAAAGTTGCTCGCCGGGCATTGGGATTATACGGAGGTTGGCCTTCTCGATCACACGCACGTCATTCACCATACCGACCGCTTGCTGGCGGCAATGGCCAAGCGTGCCGGCTGGCACGAAGTGGGCGCGCGCGACTATGAGCTCGAATCCAGTGATCAGGCGTTTCCGCCGGCTCATCCGCTGTTGACCGGAAACACGGCGGCGTCACGCTATTTGCAGCAAATCCGTCGTGCTTCGGATGCTTTCGGAACAGTGAACGAACTGGTGCGGGCGTACTTGCCGGGCGCGCGTCATGACGTTCCCCTGCTCGCCGATCCGAAAGAGGCGCGGCCGTTTCTGTCAATCGTCACGCGTACGCAAGCCAAGCGGCTTGGCAATCTGCGCGATGTCCTGCTTTGTCTCACCGCCCAGACTTGTCAGGACTTCGAAATCCTCGTCGTGACGCACAAGGTGGATGGGGAGCCGTACTATGCCGTCAGGCGGATCGTCGAAGATCTGCCGGAGTCGATTCGTAATCGTGCGCGTGTGCTTCGCTGCGATCGGGGTGGACGTACCGCGCCGCTGAATGACGGTTTTGCCGCGGCGAGAGGGCATTACGTTGCGATTCTGGACGACGATGAACTGGTTTTCGCGCACTGGGTCGAGACGTTCAAGAAGTTGAGCGAGAAGGCGGCCGGCTGTGTGTTGCGCGCGACGGTTGCCGAGCAAGACATCGTGTCGACGGGAGCCCGGCCGGATGGCGCGCTCGGATATCGGACCGTTTCGGCGATCACGACGCCGTATCCGGCGCACTTCGACCTTTTCGAACATCTGTCACAGAATTATTCGCCGCCTGTATCGCTCGCATTTCCGCGCGTCGCTTTTCAAGAGCTGGGCATTCGATTCGACGAATCGCTGGATACGGCGGAGGACTGGGACTTCGAGATGCGCACGGCCTTCGTCTGTGGCGTCGAAAGCAGCCCGGAAATTACCGGTATCTACCGAAAGTGGCGTTCCGGCGAATCGTCGTTTTCGATCCATTCGCAGGACGAATGGCGACGCGATTACGAAAAGATCGTGGCGAAGCACAACGATCAGTATCACGTGTTTCCTCCGGGCACGATCAAGCTCATCGTTGATCAGCGCAACTGGATCAAGAAGCTCGAGCACGATATCGCCGTGCTGCAGGGCGCGGCAAAACTCGATCCGTTGCGCCGGTTCTTTGTCAGGCATCCGCGTCTGTACCGGATCGTGCGGATGACCTACGACAATTCGAAGATCGTCGCTCGGAGAATCGTTCGGCGCTTGGGGTGA	MNSATYQFHYHEYSVYSNVVGLITEFGARDGVHLDIGCGYGAIAEPVRDLGLTYIGFDADEDSLRDLRSRGFEAKRIDLHRLDEVFAEIAATVNGRNVASISIIDTLEHITNGPALLDRLREFAEQRSILLVVSVPNGGHRDLGAKLLAGHWDYTEVGLLDHTHVIHHTDRLLAAMAKRAGWHEVGARDYELESSDQAFPPAHPLLTGNTAASRYLQQIRRASDAFGTVNELVRAYLPGARHDVPLLADPKEARPFLSIVTRTQAKRLGNLRDVLLCLTAQTCQDFEILVVTHKVDGEPYYAVRRIVEDLPESIRNRARVLRCDRGGRTAPLNDGFAAARGHYVAILDDDELVFAHWVETFKKLSEKAAGCVLRATVAEQDIVSTGARPDGALGYRTVSAITTPYPAHFDLFEHLSQNYSPPVSLAFPRVAFQELGIRFDESLDTAEDWDFEMRTAFVCGVESSPEITGIYRKWRSGESSFSIHSQDEWRRDYEKIVAKHNDQYHVFPPGTIKLIVDQRNWIKKLEHDIAVLQGAAKLDPLRRFFVRHPRLYRIVRMTYDNSKIVARRIVRRLG	MNIDEMAAEVLSSKKYTSVDPAVVRRVCMETAPKYPKKKEAIKAVKNELHIIHEVFLQNECYKNALSFLSQLSLDFNNAQLIDITMQIMQSHTSTKERLGDIEAVCSFLSTHISKEGSVMDIGCGFNPFALPLLHEFPATYYAYDICSEGINILNKYFSILKKGEYRAELLDAVSVTPKEKVDVALLFKLLPLLQQQKKGRGFSILEELDFDKAIVSFPIKSLGGKQKGMETFYSNLFEENLPSSLEIIEKQTFSNEMFYVIQNKTKNGGNQS	210.26	gnl|BL_ORD_ID|2268|hsp_num:0	3378			312	465	amikacin; kanamycin A; gentamicin A; gentamicin
BGC0000785.1|O-antigen_12 # 12082 # 13923 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.607	BGC0000785.1|O-antigen_12 	12082	13923	+	Loose	450	30.8018	rmtH	42.11	3003198	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGCGGTTTGATATATCCGTCGTGGTGTATCGAGAGACGGAGGAAACCCTCGACGATCTTCTCGACAGCCTCGCCGCTCAAGCATCATGCCCGGATACGGTGGTTCGTGTCTGGTTGCGCAACAACGATCCCGCCGATGCCGATCGGTGGGATCGGTTCGTGCACGATCGGTCATGGTATCCATTCGAAATTTCGATCTCGCATTCTCCGCAGAACGTGGGCTTCGGGCGCGCGCACAATGCGACGTTCGAAATGGCCGACGCCCCGTTTTTCTTTGTCTTGAATCCGGATACTCGACTGCATTCGACTGCCGTCTCGGCATTGCGGAAGGCGATAGACACGTCTGCCGGCGACGTGGGCGCCTGGGAGTTGCGGCAACTGCCGTACGAGCATCCGAAACTGTACGATCCCGTTTCGCTCAGCACGGACTGGGTGACAGGTGCCGCCGTCGTGTTCCGGCGTGCCGCGTTTGCGCAGGTGCGCGGTTTCGAGCCGCGTATCTTCATGTATGGGGAAGATGTCGACCTATCGTGGCGAATGCGCGCCGCGGGCTGGGTATTGCATTATGTGCCGCATGCTGTCGTCGTACACCCCACGTATTCGAAACCGATGGAGGCCAAACCGCTCCAGATCGCAGGCGGCGTGGTCGCATCGTTGCAATTGCGTACGAGGTTCGGGTCCTGGCTCGATATCGCTCGCGGTCTAGGTTGCTGGGTTGCCGAACTCGCGAGGCCGGCGCGCTTCCCGCATGCGCGGCGCACGCATCTGATGGCACTGGCTCGATATCTTCGGAGCGCAGCCTACTTCAGGCGCACGGGGGCACGGTATCGCAAAGGCGGTTTTCGCCCCGGTTTTCGTTTTTGGGGATATGGTGACCGACGCGACGGCGCATTTTTTGCCTTCGCGGTCGAGGAACTCGACGCGCGCACGGTGCCGCTTGTCTCGATCATCGTGCGAACGCATCGCCGACCGGCATTGTTGCGGGAGGCGCTGATGTCGCTGTCGCATCAAACCTATCCGCGTGTCGAAGTCATTGTCGTCGAGGACGGCGAGCCGAATAGCCGCGCGATGATCGAGCGCGAATTTGCAGGGCGCCTTGATATCCGCTATGAGGCGACGGGCATGCCGGTAGGCAGGAGTGCCGCCGGGAATCTGGGGCTTTCGCTCGCCGCCGGGGAATGGCTGGGATTTCTTGACGACGACGACCAGTTCTACGCAGACCACGTCGAGGCAATAATGCAGGTCGCGCGAAGCGGTACGAACCGGGCAGTCTATGGTGCGTCGCACGAGATTCCGACCGAATTTGCACAATTGACGGACGAGGCCGCGACATATCGCGAAGAGCCCGCGTCGCTCAAGTATCGGCCATATTCCCGCCTGGCGATGTGGCAGGAGAACCTTGCGCCGATTCAAGCAGTCCTCTTCCATCGAAGCTTGTATGACGAATTGGGCGGATTTGACGAGGACCTCGATCAACTCGAAGACTGGGTGCTGTGGGTACGCTATTCGTGTGCGACTGACTTCTCTTCGTTCCTGCGGGTGACATCACGCTACCGGGTGCCCATGGCGGCCAAGGTTGCCGTTGAGCGTCAGGCCAAGCTGCATGAAGCCTATGCCGTCGCCCTGGAGCGACAGCGAGCGATGCGAGTGACGCTTAGCCCGTTCGACGTTGTCGCCATGGCGGAAGAGCAGGCCCGTCGGCATGCTATCGTCCACGTTTCGAGGCAAACCGCGCGAAAGCTGATCGTGCGAGTGCCGTTCATGCGAACGTTGTTATCGAGCCAGGCGGGATGGCGACGGCGCATGAGAGCGCTATATCGTCGAATGTCGCCGCGCTCCTGA	MRFDISVVVYRETEETLDDLLDSLAAQASCPDTVVRVWLRNNDPADADRWDRFVHDRSWYPFEISISHSPQNVGFGRAHNATFEMADAPFFFVLNPDTRLHSTAVSALRKAIDTSAGDVGAWELRQLPYEHPKLYDPVSLSTDWVTGAAVVFRRAAFAQVRGFEPRIFMYGEDVDLSWRMRAAGWVLHYVPHAVVVHPTYSKPMEAKPLQIAGGVVASLQLRTRFGSWLDIARGLGCWVAELARPARFPHARRTHLMALARYLRSAAYFRRTGARYRKGGFRPGFRFWGYGDRRDGAFFAFAVEELDARTVPLVSIIVRTHRRPALLREALMSLSHQTYPRVEVIVVEDGEPNSRAMIEREFAGRLDIRYEATGMPVGRSAAGNLGLSLAAGEWLGFLDDDDQFYADHVEAIMQVARSGTNRAVYGASHEIPTEFAQLTDEAATYREEPASLKYRPYSRLAMWQENLAPIQAVLFHRSLYDELGGFDEDLDQLEDWVLWVRYSCATDFSSFLRVTSRYRVPMAAKVAVERQAKLHEAYAVALERQRAMRVTLSPFDVVAMAEEQARRHAIVHVSRQTARKLIVRVPFMRTLLSSQAGWRRRMRALYRRMSPRS	MTIEQAAADILSSKKYQLLCPDTVVRILTQEWGRHKKPKQAVERTRERLHGICGAYLAPQVEKQASTALAAGDVQKALALHASTRERLDTYPQLYQFVFENNLPARVLDIACGLNPLMLHRQGVASVWGCDIHQGLGNVLTPYAQKHGWDFTFALHDVLCAPVAASGDMALVFKLLPLLEREQPGAALALLRTLDAPVICVSFPTRSLGGRGKGMHQHYATWFEGLVAPHFTVQHHTLIGDELLYRIQPNPA	243.25	gnl|BL_ORD_ID|33|hsp_num:0	41			9	123	amikacin; tobramycin; arbekacin; gentamicin A; gentamicin
BGC0000785.1|O-antigen_14 # 14825 # 15790 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.666	BGC0000785.1|O-antigen_14 	14825	15790	+	Loose	1200	29.6462	arnA	45.16	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAGCAGGGTCATCGTTACGGGCGCGAACGGGTTCGTCGGGCGCGCGCTCTGCCGCGCGCTGCTCGCGGCCGGGCACGAGGTTACGGGGCTCGTGCGCCGCCGGGGTGTTTGCGCCGAAGGCGTGTCGGAGTGGGTGCACGAGGCTGATGATTTCGATGGTGTCGCCGACCGTTGGCCTGCGGGTCTGCAGGTGGATGCCGTCGTGCATCTCGCCGCCCGCGTTCATATGATGCGTGACCGCTCGCCCGATCCGGACGCTGCGTTTCGTGCATCGAACGTTGCGGCGACGATGCGCGTGGCTCGTGCTGCACAGCAGCAAGGCGCAAGACGGTTCGTGTTTCTGAGCAGCGTCAAAGCGATTGCTGAATCCGACGGCGGCACGCCGCTGTGCGAGAATTCGACGCCGGCGCCGCAGGACGCTTACGGACGCTCGAAGCTCGAAGCCGAACGTGCGCTTGAACAATTGCGCGACGAACTGAGCTTCGACACGGTCATCGTCAGGCCGCCGCTCGTGTATGGCCCGGGGGTTCGCGCCAATTTCCTGAGCCTGATGCGTGCGGTATCACGAGGCGTGCCGCTGCCGCTGGGAGCGGTGCGCGCGCGACGCAGTATGGTGTACGTCGACAATCTCGCCGACGCGGTGATGCGCTGCGTGACGGAACCAGCGGCCACGAACGGGTGCTTTCATGTCGCGGATAGTGATATGCCGCCGACCATTGCCGAATTGCTCGATGACATCGGGCATCATCTTGGACGCCCCGCACGTCTGTTGCCCGTGCCGGAGCGTTTGCTGCGCGTCGCGGGGGCGTTGACGGGGCGCGCGGCGCAGATCGATCGTCTGACGAGCGACCTGCGGCTCGACACGACGCACATTCGCACGGTGCTCGACTGGCGTCCGCCGCGCTCGAGCGAAGAGGGGCTCGCCGAAACGGCGTGCTGGTTCAAGTCGCTGGGCCGACGCTAG	MSRVIVTGANGFVGRALCRALLAAGHEVTGLVRRRGVCAEGVSEWVHEADDFDGVADRWPAGLQVDAVVHLAARVHMMRDRSPDPDAAFRASNVAATMRVARAAQQQGARRFVFLSSVKAIAESDGGTPLCENSTPAPQDAYGRSKLEAERALEQLRDELSFDTVIVRPPLVYGPGVRANFLSLMRAVSRGVPLPLGAVRARRSMVYVDNLADAVMRCVTEPAATNGCFHVADSDMPPTIAELLDDIGHHLGRPARLLPVPERLLRVAGALTGRAAQIDRLTSDLRLDTTHIRTVLDWRPPRSSEEGLAETACWFKSLGRR	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	48.49	gnl|BL_ORD_ID|1513|hsp_num:0	1643			951	1044	polymyxin B
BGC0000785.1|O-antigen_15 # 15808 # 16818 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.601	BGC0000785.1|O-antigen_15 	15808	16818	+	Loose	700	26.1794	PDC-242	32.56	3006620	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGTTCCAACTGAATTTGACCATCTTGTCCGCGATGGCGTTCGCATCGATCGCTGCGATCGTCACCGCGCTTATTCTCAAATGGCTTCTCGCGAGCGGATGGGCATGGCGGCTGGCGACTGATGTGCCGAACGCTCGCTCGATGCACACACGGCCGACGCCGCGTATGGGCGGCTGGGGGATCGTGCCGGTTGGCGCGGTGGCCATTGGGATTGCCGCGCCACATCTATGGGGAATTGTCGCGGCGATGCTGTTTCTGGCGATCGTCTCTCATATCGACGACCGTCGGGGGCTACCCGCGCGGGTTCGATTCGCTGCCCACCTCATCGCGTCCGCGGCGATTGCCGCGTTGTATTCGGGGGGCTTGGCATGGTTCTGGATCCCCATCGTCGCCGTCGGGCTCGCGTGGCTGATCAACCTGTATAACTTCATGGACGGCGCAGATGGCCTTGCCGGGGGAATGACCGTCTTCGGTTTCGGCAGCTATGCGTTTGCAGCACTCGCAGGACCCCATCCATCTGTCGGATTGGGTTGGGCGTGTGCGGCGATTGCGGGTGCGGCGGCGGGATTCCTGCTCCTCAACTTCCATCCGGCCAAGCTTTTCCTGGGCGACGCGGGTTCGATTTCGCTCGGTTTGCTCGCCGGGGCGTTCGGCTATTGGGGATGGCGTCATGCGGTCTGGCCGCTGTGGTTTCCGCTCGTTGTCTTTGCACCGTTTATTGCCGATGCATCTGTAACATTGTTGCGACGTTTGTTACGAAGGGAAAAGTTCTGGGAAGCACATCGAGAGCATTATTATCAGCGCATGGTGCGCTTGGGCGTCGGGCACGCGCGGACAGCGCTCTGCTGGTACGCGACCATGCTGGTCGGCGCCGTCGTGTCGCTTTCGGTATTGGCATGTTCTACCGCGGTCCAGTGGATGACTATCGCCGCTTGGGGTTCGATCCTGTTTCTCTTGGGCGTAGCCATCGATGTGTGCTGGAGTCGCTTCCAAATACTTACATCAAAATAA	MFQLNLTILSAMAFASIAAIVTALILKWLLASGWAWRLATDVPNARSMHTRPTPRMGGWGIVPVGAVAIGIAAPHLWGIVAAMLFLAIVSHIDDRRGLPARVRFAAHLIASAAIAALYSGGLAWFWIPIVAVGLAWLINLYNFMDGADGLAGGMTVFGFGSYAFAALAGPHPSVGLGWACAAIAGAAAGFLLLNFHPAKLFLGDAGSISLGLLAGAFGYWGWRHAVWPLWFPLVVFAPFIADASVTLLRRLLRREKFWEAHREHYYQRMVRLGVGHARTALCWYATMLVGAVVSLSVLACSTAVQWMTIAAWGSILFLLGVAIDVCWSRFQILTSK	MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALTQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAGPGPLDAEGYGVKASAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR	84.63	gnl|BL_ORD_ID|4310|hsp_num:0	5380			684	813	
BGC0000785.1|O-antigen_18 # 19715 # 19915 # -1 # ID=1_18;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.587	BGC0000785.1|O-antigen_18 	19715	19915	-	Loose	500	22.3274	APH(3')-VIIa	47.06	3002654	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	CCGGTCAAGGAACTGTGCAGGAAGCATGGGTTCAGTGACGCGTCGTTCTACACCTGGCGCGCGAAGTTCGGCGGCATGGAAGTCTCGGAAGCCCGCCGGCTCAAGGGCCTCGAGGTGGAGAATGCCCGACTGAAGAAACTGCTGGCCGAAGCAATGCTCGATATGGAAGCGTTGAAGGTTGTCGTCAAGGGAAAGCCCTGA	PVKELCRKHGFSDASFYTWRAKFGGMEVSEARRLKGLEVENARLKKLLAEAMLDMEALKVVVKGKP	MKYIDEIQILGKCSEGMSPAEVYKCQLKNTVCYLKKIDDIFSKTTYSVKREAEMMMWLSDKLKVPDVIEYGVREHSEYLIMSELRGKHIDCFIDHPIKYIECLVNALHQLQAIDIRNCPFSSKIDVRLKELKYLLDNRIADIDVSNWEDTTEFDDPMTLYQWLCENQPQEELCLSHGDMSANFFVSHDGIYFYDLARCGVADKWLDIAFCVREIREYYPDSDYEKFFFNMLGLEPDYKKINYYILLDEMF	26.40	gnl|BL_ORD_ID|226|hsp_num:0	251			501	552	neomycin; kanamycin A
BGC0000785.1|O-antigen_17 # 18858 # 19691 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.618	BGC0000785.1|O-antigen_17 	18858	19691	-	Loose	390	25.409	MexZ	31.48	3003709	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTTGGCGATTCGGGAGAAGGTCAACATCTCCGAGCGCCGCGCCTGCCGGCTTGTCGGGCTTTCTCGCAGCGTGCTGCATTACGACGCGAAGCCGGACCACGAGAATGAGGTGCTCGCGGCGCGTCTGGTGAAGTTGGCGCACGAACGTCGTCGATTCGGCTACCGCCGACTGCACGCCCTGGTGGAACGCGAAGGCACGCACGCCAATCACAAGCGCATCTATCGCCTGTACCGTGAGGCAGGGCTGGCTGTGCGGCGCCGTCGCAAGCGCCACGGCGTAATGATTGAGCGCGAGCAACTGGCATTGCCGGGCGCACCCAACGAGGTATGGTCAATCGATTTCGTGATGGATGCGCTTTCCAACGGCCGGCGCGTGAAGTGCCTGACCGTCGTCGACGATTTCACGAAAGAGGCTGTCGACATCGTCGTCGACCATGGCATCTCAGGTTTGTATGTCGCTCGGGCATTGGACCGTGCAGCTCGCTTCCGTGGCTATCCCAAGGCGGTGCGAACAGACCAGGGACCCGAATTTACGAGCCGCGCGCTTGACCAGTGGGCGTATGCGAACGGCGTCACGCTGAAGTTGATTCAGGCGGGCAAGCCCACGCAGAATGCGTACATCGAATCGTTCAACGGCAAGTTCCGCGACGAATGCCTTAACGAGCACTGGTTCACGACGCTCGCGCACGCTCGGGCAGTCATCGCGGCATGGCGTCAGGACTACAACGAGCAAAGGCCGCACAGCGCACTGAACTACCTTGCGCCGTCAGAGTTTGCGGCGAAACATCGGGCAACCGCGGACGCTCCTGCCGCTTTCCAGGAGTTGGTTTAA	VLAIREKVNISERRACRLVGLSRSVLHYDAKPDHENEVLAARLVKLAHERRRFGYRRLHALVEREGTHANHKRIYRLYREAGLAVRRRRKRHGVMIEREQLALPGAPNEVWSIDFVMDALSNGRRVKCLTVVDDFTKEAVDIVVDHGISGLYVARALDRAARFRGYPKAVRTDQGPEFTSRALDQWAYANGVTLKLIQAGKPTQNAYIESFNGKFRDECLNEHWFTTLAHARAVIAAWRQDYNEQRPHSALNYLAPSEFAAKHRATADAPAAFQELV	MARKTKEESQKTRDGILDAAERVFLEKGVGTTAMADLADAAGVSRGAVYGHYKNKIEVCLAMCDRAFGQIEVPDENARVPALDILLRAGMGFLRQCCEPGSVQRVLEILYLKCERSDENEPLLRRRELLEKQGQRFGLRQIRRAVERGELPARLDVELASIYLQSLWDGICGTLAWTERLRDDPWNRAERMFRAGLDSLRSSPYLLLADA	131.90	gnl|BL_ORD_ID|4693|hsp_num:0	2223			279	441	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
